The French unit of German pharmaceuticals firm Merck has been charged with willful commercial deception for failing to inform patients of changes to a thyroid treatment that could result in serious side-effects.
A court in 2020 ordered the company to pay compensation to more than 3,300 plaintiffs in a civil hearing of the same charges. An appeal against that ruling was rejected by France's supreme court earlier this year.
